Skip to main content
SpringerLink
Log in

Expression of survivin, cyclinD1, p21WAF1, caspase-3 in cervical cancer and its relation with prognosis

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

The implications of Survivin, CyclinD1, p21WAF1, Caspase-3 in the development, progression and prognosis in cervical cancer were investigated. By using immunohistochemical SP method, the expression of Survivin, CyclinD1, p21WAF1, Caspase-3 was detected in 41 cases of cervical cancer, 17 cases of cervical intraepithelial neoplasia (CIN) and 10 cases of normal tissues, and their relation with pathological grade, clinical stage, metastasis and survival time was analyzed. The results showed that the positive expression rate of Survivin, CyclinD1 in cervical cancer was significantly higher than in CIN group and normal control group (P<0.05). The median survival time in the patients with cervical cancer positive for Survivin and CyclinD1 was significantly shorter than in those with negative expresion (P<0.05). The expression of both Survivin and CyclinD1 was not related with tumor grade, clinical stage and metastasis (P>0.05). The positive expression rate of p21WAF1, Caspace-3 in cervical cancer was significantly lower than in CIN group and normal control group (P<0.05), and had a close relation with tumor grade (P<0.05). The expression of Survivin in cervical cancer in cervical cancer was negatively associated with that of Caspase-3 (P<0.01), but positively with that of CyclinD1 (P<0.01). Cox Multivariate analysis revealed that Survivin was the independent prognostic indicator influencing the survival time of the patients with cervical cancer (P<0.05). It was suggested that the high expression of Survivin or CyclinD1, and low expression of p21WAF1 or Caspace-3 was closely correlated with the development of cervical cancer. Survivin and CyclinD1 could be used as a useful indicator to predict the prognosis of cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bao R, Connolly D C, Murphy Met al. Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst, 2002, 94:522

    Article  CAS  PubMed  Google Scholar 

  2. Suzuki A, Ito T, Kawano Het al. Survivin initiates procaspase-3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene, 2000, 19:1346

    Article  CAS  PubMed  Google Scholar 

  3. Suzuki A, Hayashida M, Ito Tet al. survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4α and Cdk2/CyclinE complex activation. Oncogene, 2000, 19:3225

    Article  CAS  PubMed  Google Scholar 

  4. Kim H S, Shiraki K, Park S H. Expression of survivin in CIN and invasive sqamous cell carcinoma of uterine cervix. Anticancer Res, 2002, 22:805

    CAS  PubMed  Google Scholar 

  5. Yamamoto T, Tanigawa N. The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microse, 2001, 34:207

    Article  CAS  Google Scholar 

  6. Hortwell L H, Kastan M B. Cell cycle control and cancer. Science, 1994, 266:1821

    Article  ADS  Google Scholar 

  7. Nichols G E, Williams M E, Gaffey M Jet al. CyclinD1 gene expression in human cervical neoplasia. Mod Pathol, 1996, 9:418

    CAS  PubMed  Google Scholar 

  8. Bae D S, Cho S B, Kim Y Jet al. Aberrant expression of CyclinD1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol, 2001, 81:341

    Article  CAS  PubMed  Google Scholar 

  9. Gillett C, Smith P, Gregory Wet al. CyclinD1 and prognosis in human breast cancer. Int J Cancer, 1996, 69:92

    Article  CAS  PubMed  Google Scholar 

  10. Betticher D C, Heighway J, Hasleton P Set al. Prognostic significance of CCND1(cyclinD1) over expression in primary resected non-small-cell lung cancer. Br J Cancer, 1996, 73:294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. El-Diery W S, Harper J W, O'Connor P Met al. WAF1/CIPI is induced in p53-mediated G1 arrest and apoptosis. Cancer Res, 1994, 54:1169

    Google Scholar 

  12. Lu X, Toki T, Konishi Iet al. Expression of p21 waf in adenocarcinoma of the uterine cervix: a possible immunohistochemical maker of a favorable prognosis. Cancer, 1998, 15:2409

    Article  Google Scholar 

  13. Schwandner O, Bruch H P, Broll R. p21, p27, cyclinD1, and p53 in rectal cancer: immunohistology with prognostic signficance? Int J Colorectal Dis, 2002, 17:11

    Article  CAS  PubMed  Google Scholar 

  14. Sun B H, Zhang J, Wang B Jet al. Analysis of in vivo patterns of caspase 3 gene expression in primary hepato-cellular carcinoma and its relationship to p21 (WAF1) expression and hepatic apoptosis. World J Gastroenterol, 2000:356

  15. Cheung T H, Chung T K H, Lo K Wet al. Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix. Gynecol Oncol, 2002, 86:14

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China

    Lu Shi, Zhang Baohua & Wang Zehua

Authors
  1. Lu Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhang Baohua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wang Zehua
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

LU Shi, female, born in 1967, Doctorial Candidate

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, L., Baohua, Z. & Zehua, W. Expression of survivin, cyclinD1, p21WAF1, caspase-3 in cervical cancer and its relation with prognosis. Current Medical Science 25, 78–81 (2005). https://doi.org/10.1007/BF02831393

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02831393

Key words

Search

Navigation